ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2658

Hypovitaminosis D in Lupus Nephitis

Alicia Yupe1, Emma Puron Gonzalez2, Esteban Salatino3, Jessica Santana4, Montserrat Ochoa4, Rosa Elena Cervantes-Ramirez5, Eli Marisol Saldaña6, gabriel Calderon7, Brissia Ceniceros8, Ulices de la Cruz9, Monica Meza10 and Sergio Cerpa Cruz6, 1Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala., Guatemala, Guatemala, 2UDEM/ITESM, San Pedro Garza Garcia, Mexico, 3Faculty of Medical Sciences, Universidad de San Carlos de Guatemala., Guatemala, GU, 4Hospital Civil "Fray Antonio Alcalde", Guadalajara, Mexico, 5Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico, Distrito Federal, Mexico, 6Hospital Civil de Guadalajara, Guadalajara, Mexico, 7Hospital Civil de Guadalajara, Monterrey, Mexico, 8Hospital Civil de Guadalajara, Torreón, Coahuila de Zaragoza, Mexico, 9Hospital Civil "Fray Antonio Alcalde", Guadalajara, 10Centro Universitario de Ciencias de la SAlud, Guadalajara

Meeting: ACR Convergence 2024

Keywords: Lupus nephritis, Nephritis, nutrition, Renal, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: ARP Interprofessional II: Psychology & Practice

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: The prevalence of vitamin D deficiency is higher in patients with systemic lupus erythematosus (SLE) compared to the healthy population, and recent studies have observed a higher prevalence of hypovitaminosis D in patients with associated kidney disease.  This deficiency has been proposed as a risk factor for a higher incidence and activity of autoimmune diseases. The present study aims to determine the prevalence of hypovitaminosis D and its correlation with clinical and renal activity and histopathological findings of renal biopsy in patients with SLE and lupus nephritis (LN).

Methods: Analytical cross-sectional study, in patients with SLE according to the 2019 EULAR/ACR criteria and lupus nephritis by renal biopsy according to ISN/RPS of 2003. A measurement of disease activity was performed by SLEDAI 2K considering high activity > 4 points, and renal activity through creatinine, BUN, urinary sediment, albuminuria, urinary creatinine protein ratio, 24-hour urine protein count, GFR, renal biopsy report, activity index and chronicity. Serum vitamin D levels were measured by ELISA (Human soluble 25-OH Vitamin D ELISA Kit Eagle Bioscences), considering hypovitaminosis D < 30 ng/mL. The sample calculation was carried out with the formula for difference of proportions with a statistical power of 85% requiring 24 patients. Quantitative variables were tested for Shapiro-Wilk normality and expressed as means and standard deviations. Qualitative variables were reported as frequencies and percentages. In the inferential analysis, the continuous variable of vitamin D levels was analyzed with the Student’s T test. Categorical variables were analyzed with the Chi2 test or Fisher’s exact test. The correlation analysis was performed using Pearson’s coefficient and Kendall’s Tau b for continuous and ordinal variables respectively. In all cases, bilateral statistics were performed with an alpha value < 0.05. SPSS v21 software was used for data analysis and Graph Pad Prism software was used to create graphs.

Results: Twenty-four patients with systemic lupus erythematosus were studied, divided into two groups: the first included 12 patients without renal involvement and the second included 12 patients with LN. 58% of the 24 patients had hypovitaminosis D, of which there was a higher prevalence in patients with LN than in the SLE group without kidney disease, 75% vs 42% (Table 1). Vitamin D level had a moderate negative correlation (Figure 1) with 24-hour urine protein count (r =-0.594, p=0.042) in patients with LN. In the renal biopsy lesions, 100% had rupture of the glomerular basement membrane (GBM) and interstitial inflammation, followed by endocapillary hypercellularity in 91.7%, but none was specifically correlated to hypovitaminosis D.

Conclusion: Hypovitaminosis D has a higher prevalence in patients with lupus nephritis compared to patients with SLE without kidney disease. In patients with lupus nephritis, the greater the proteinuria, the greater the vitamin D deficiency.

Supporting image 1

SLE: systemic lupus erythematosus, NL: lupus nephritis, SD: standard deviation, SLEDAI: systemic lupus erythematosus activity index, VD3: vitamin D3.

Supporting image 2

Figure 1: Correlation between vitamin D levels and 24-hour protein in urine collection in patients with lupus nephritis. * Pearson correlation coefficient.


Disclosures: A. Yupe: None; E. Puron Gonzalez: None; E. Salatino: None; J. Santana: None; M. Ochoa: None; R. Cervantes-Ramirez: None; E. Saldaña: None; g. Calderon: None; B. Ceniceros: None; U. de la Cruz: None; M. Meza: None; S. Cerpa Cruz: None.

To cite this abstract in AMA style:

Yupe A, Puron Gonzalez E, Salatino E, Santana J, Ochoa M, Cervantes-Ramirez R, Saldaña E, Calderon g, Ceniceros B, de la Cruz U, Meza M, Cerpa Cruz S. Hypovitaminosis D in Lupus Nephitis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/hypovitaminosis-d-in-lupus-nephitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypovitaminosis-d-in-lupus-nephitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology